COMPANY PROFILE

Innovac Therapeutics

Biotechnology company developing innovative RNA-based vaccines for unmet medical needs with proprietary technology platforms

Cambridge, United StatesFounded 2022Biotech & Life Sciences

Valuation $0–100M Latest valuation · 2023

Headcount <100 Current team size

Total funding $10–50M Disclosed equity funding

Unlock exact values

About Innovac Therapeutics

Innovac Therapeutics is a biotechnology company focused on developing innovative vaccines to address unmet medical needs. Utilizing proprietary RNA technology platforms and advanced manufacturing capabilities, Innovac aims to create both therapeutic and prophylactic vaccines. The company operates in the biotechnology sector, primarily serving patients with high unmet medical needs in the US, China, and global markets. Innovac's business model revolves around research and development, leveraging its proprietary technology to bring new vaccines to market. Revenue is generated through the commercialization of these vaccines, either through direct sales or partnerships with larger pharmaceutical companies. Innovac is headquartered in Cambridge, Massachusetts, and is characterized by a high-performance culture that rewards creative solutions and rapid innovation.

Source: Dealroom company data

At a glance

Status: Operational
Founded: 2022
Headquarters: Cambridge, United States
Employees: 14
Open positions: None listed
Dealroom signal: 68.5/100
Industry: Health
Sub-industry: BioTechnology
Sector: Biotech & Life Sciences, Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Business model: Manufacturing
Client focus: b2b
Links: Website LinkedIn

Latest news

Press, funding announcements and product moves mentioning Innovac Therapeutics.

See all news

Funding history

1 recorded event

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
SEED✓Equity / VC	Sep 2023	$18M	$72M	Yunion Healthcare Ventures · Vision Plus Capital · Elikon Venture · TG Sino-Dragon Fund	↗

Showing the latest 1 of 1 recorded eventsBook a demo for the full funding history →

Growth signals

Innovac Therapeutics website traffic

Latest recorded traffic for Innovac Therapeutics is 1.3K monthly website visits, down 35% over the last three months. Innovac Therapeutics's team grew 0% over the past year.

Latest monthly visits1.3K 3-month web change-35% 1-year team growth0%

Monthly website visitsJun 2023–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
RTReNAgade TherapeuticsRevolutionizing RNA medicine with integrated delivery, coding, editing, and insertion technologies to precisely correct diseases	Cambridge, United States	Acquired	23	$300M	$1.2B
NENeuroCytonixInnovative brain regeneration technology restoring nervous system structure with proven clinical efficacy	Rockville, United States	Operational
CPCardurion PharmaceuticalsTranslating the science of cardiac myocyte signaling pathways into groundbreaking therapeutics	Burlington, United States	Operational
ADAnimol DiscoveryBiopharmaceutical company focused on identifying and developing next- generation antiparasitics and therapeutics	Boston, United States	Operational
BBBaiming Xinkang BiotechnologyA clinical stage biopharmaceutical company developing new treatments for allergy and other diseases	Hangzhou, China	Operational
GLGlytechGlycan technology for biopharmaceutical drug development	Kyoto, Japan	Operational
MAMatterworksAccelerating discovery and engineering through faster and more comprehensive metabolomic screening	Somerville, United States	Operational
MBMBDSpecializing in precision medicine and new drug development through 3D cell culture platform technology	South Korea	Operational